The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: A systematic review and meta-analysis
- 1 October 2016
- journal article
- research article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 83, 989-997
- https://doi.org/10.1016/j.biopha.2016.08.003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Efficacy and Safety of Selective H1-Antihistamine versus Leukotriene Receptor Antagonist for Seasonal Allergic Rhinitis: A Meta-AnalysisPLOS ONE, 2014
- Rapid induction of inflammatory lipid mediators by the inflammasome in vivoNature, 2012
- Efficacy of Second-Generation Antihistamines in Patients with Allergic Rhinitis and Comorbid AsthmaJournal of Asthma, 2011
- Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and childrenClinical Therapeutics, 2009
- Selecting the Optimal Oral Antihistamine for Patients with Allergic RhinitisDrugs, 2006
- Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2Journal of Biological Chemistry, 2005
- Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activityEuropean Journal of Pharmacology, 2004
- Advances in H1-AntihistaminesThe New England Journal of Medicine, 2004
- Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests.Allergy, 2002
- Quality of life in allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999